Cigna Group $CI Stock: Aberdeen Group plc Grows Position

Aberdeen Group plc grew its position in Cigna Group (NYSE:CI – Free Report) by 389.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,078,857 shares of the health services provider’s stock after acquiring an additional 858,488 shares during the quarter. Aberdeen Group plc’s holdings in Cigna Group were worth $283,907,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of CI. BlackRock Inc. increased its holdings in Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares in the last quarter. GQG Partners LLC acquired a new stake in Cigna Group in the second quarter valued at approximately $1,628,918,000. Bank of America Corp DE grew its position in Cigna Group by 8.8% in the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock valued at $848,821,000 after acquiring an additional 256,677 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Cigna Group by 10.8% during the first quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after acquiring an additional 236,340 shares in the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of Cigna Group during the second quarter valued at about $542,779,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

Cigna Group Price Performance

Shares of NYSE:CI opened at $296.79 on Friday. The firm has a 50 day moving average of $287.53 and a 200-day moving average of $282.70. The stock has a market capitalization of $78.21 billion, a PE ratio of 13.10, a PEG ratio of 1.11 and a beta of 0.25. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. Cigna Group has a 12 month low of $257.85 and a 12 month high of $318.05.

Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, topping analysts’ consensus estimates of $7.52 by $0.46. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The firm had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. During the same quarter in the prior year, the business earned $7.83 earnings per share. The business’s revenue for the quarter was up 5.6% compared to the same quarter last year. On average, equities research analysts predict that Cigna Group will post 30.71 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s payout ratio is currently 27.54%.

Analyst Ratings Changes

Several research analysts recently commented on the company. Royal Bank Of Canada reiterated an “outperform” rating and issued a $337.00 price target on shares of Cigna Group in a research note on Thursday, October 1st. Guggenheim decreased their price target on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating for the company in a report on Friday, November 6th. Sanford C. Bernstein lifted their target price on Cigna Group from $387.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday. Piper Sandler dropped their price objective on shares of Cigna Group from $370.00 to $360.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, UBS Group reaffirmed a “buy” rating on shares of Cigna Group in a research note on Thursday, October 1st. Fourteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $336.90.

Check Out Our Latest Research Report on CI

Top Cigna Group Stories

These are some of the CI stories that stood out recently:

Cigna Group Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.